Unique Considerations for Designing Cosmetics Clinical Trials
Explore the essential elements of designing clinical trials for cosmetics, from ethical considerations to regulatory requirements.
FDA’s Final Rule on LDTs and IVDs: Key Takeaways and Possible Implications for Diagnostics Developers
The FDA has released its Final Rule to end its long-standing enforcement discretion for LDTs developed and utilized in a single laboratory. Read on to discover how this impacts diagnostics developers.
POC Oncology Diagnostics: Advantages and Considerations for Development
Learn more about how these innovative diagnostics make cancer screening more accessible and convenient for all, as well as strategies to include in your next point-of-care oncology diagnostics study.
Clinical trials are still taking too long to run – here’s how AI can help
Discover how modern CROs are leveraging artificial intelligence to overcome common challenges and enhance clinical trial efficiency.
Your trial, solved.
Subscribe for more content
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
